key: cord-0746659-qfcnpg24
authors: Sai, Brundavanam Venkata Krishna; Kumar, Hema; Arun Babu, Thirunavukkarasu; Chaitra, Raghuvamsi; Satapathy, Diptirekha; Kalidoss, Vinoth Kumar
title: Clinical Spectrum of Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19 Infection
date: 2022-01-30
journal: Indian J Pediatr
DOI: 10.1007/s12098-021-04054-3
sha: f8fbaa5e5742b51e8134404642921174feb841c8
doc_id: 746659
cord_uid: qfcnpg24

nan

To the Editor: Multisystem inflammatory syndrome in children (MIS-C) is a potentially life-threatening complication of COVID-19 that may occur during or after recovery from acute infection [1] . Very limited clinical data are available on MIS-C from India till date [2, 3] . This prospective observational study was conducted in a tertiary care pediatric hospital of South India to describe the clinical presentation of children with MIS-C. Seventy-four children below 12 y of age who satisfied the World Health Organization's diagnostic criteria for MIS-C were included in the study [4] . Clinical parameters were recorded during hospital course. Forty-two children (56.8%) were under 5 y and 32 children (43.2%) belonged to 6-12 y age group. The male:female ratio was 1:1.9. COVID RT-PCR was negative in all patients. Positive COVID antibodies and history of contact with COVID positive case were seen in 93% and 73% of cases, respectively. Dull activity (67.6%), poor feeding (59.5%), vomiting (41.9%), abdominal pain (31.1%), loose stools (23.0%), cough (16.2%), and cold (16.2%) are common symptoms of MIS-C, and the common signs were rash (51.4%), conjunctival congestion (41.9%), hypotension (35.1%), tachycardia (33.8%), hypoxemia (16.3%), and tachypnea (13.5%). Among systems, gastrointestinal system was the commonly affected (62%) followed by hepatic (54%), cardiovascular (35%), and renal (26%) systems. Common laboratory abnormalities seen in the study population includes elevated C-reactive protein (CRP) (82%), elevated erythrocyte sedimentation rate (ESR) (75%), leukocytosis (47%), high N/L ratio (22%), thrombocytopenia (39%), elevated serum ferritin (44%), elevated D-dimer (77%), and elevated LDH (33%). To the best of our knowledge, our study is reporting the largest case series of MIS-C published yet from India, with a total of 74 cases. However, large-scale descriptive studies from other parts of India are needed to confirm these preliminary findings.

Pathogenesis of COVID-19 and multi-system inflammatory syndrome in children

Multisystem inflammatory syndrome in children with COVID-19 in Mumbai

Clinical profile and short-term outcome of children with SARS-CoV-2 related multisystem inflammatory syndrome (MIS-C) treated with pulse methylprednisolone

Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19